Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Haplo-Identical Stem Cell Transpant Is a Feasible and Safe Treatment Option for Patients with Severe Thalassemia

Suradej Hongeng, MD, Usanarat Anurathapan, MD, Samart Pakakasama, MD, Duantida Songdej, Nongnuch Sirachainan, MD, Ampaiwan Chuansumrit, MD, Borje S Andersson, MD PhD

Blood (2018) 132 (Supplement 1): 3448.

https://doi.org/10.1182/blood-2018-99-115459

Published: 2018

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression (PTIS) and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: Safe Approach and Excellent Disease Control

Suradej Hongeng, MD, Samart Pakakasama, MD, Usanarat Anurathapan, MD, Borje Andersson, MD PhD

Blood (2014) 124 (21): 2571.

https://doi.org/10.1182/blood.V124.21.2571.2571

Published: 2014

Journal Articles

Efficacy of Deferasirox on Iron Chelation in Thalassemia Patients After Hematopoietic Stem Cell Transplantation

Samart Pakakasama, MD, Somtawin Sirireung, MSc, Bandit Thinkhamrop, PhD, Nongnuch Sirachainan, MD, Suradej Hongeng, MD

Blood (2011) 118 (21): 3136.

https://doi.org/10.1182/blood.V118.21.3136.3136

Published: 2011

Journal Articles

A Cost-Utility and Budget Impact Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Thalassemic Patients In Thailand.

Suradej Hongeng, Samart Pakakasama, Nongnuch Sirachainan, MD, Ampaiwan Chuansumrit

Blood (2010) 116 (21): 1536.

https://doi.org/10.1182/blood.V116.21.1536.1536

Published: 2010

Journal Articles

Outcomes of Children with Acute Lymphoblastic Leukemia Treated with 2 Consecutive Protocols: Ramathibodi Hospital Experience

Pacharapan Surapolchai, MD, Samart Pakakasama, MD, Nongnuch Sirachainan, MD, Usanarat Anurathapan, Ampaiwan Chuansumrit, Suradej Hongeng, MD

Blood (2008) 112 (11): 3951.

https://doi.org/10.1182/blood.V112.11.3951.3951

Published: 2008

Journal Articles

Genetic Polymorphisms of β-Cell Differentiation Confer Risk of Alterations of Glucose Metabolism in Survivors of Childhood Acute Lymphoblastic Leukemia.

Pacharapan Surapolchai, MD, Suradej Hongeng, MD, Pat Mahachoklertwattana, Samart Pakakasama, MD, Angkana Winaichatsak, MD, Nittaya Wisanuyothin, Ekawat Pasomsub, Surakameth Mahasirimongkol, MD, Nongnuch Sirachainan

Blood (2008) 112 (11): 1908.

https://doi.org/10.1182/blood.V112.11.1908.1908

Published: 2008

Journal Articles

The Effectiveness of Recombinant Factor VIIa in the Treatment of Bleeding in Pediatric Patients: A Ten-Year Experience from 1997 to 2007.

Ampaiwan Chuansumrit, MD, Sumate Teeraratkul, MD, Suporn Tripongkaruna, MD, Suthep Wanichkul, MD, Nongnuch Sirachainan, MD, Samart Pakakasama, MD, Pracha Nuntnarumit, MD, Suradej Hongeng, MD

Blood (2007) 110 (11): 3949.

https://doi.org/10.1182/blood.V110.11.3949.3949

Published: 2007

Journal Articles

Adenovirus and BK Virus Co-Infection in the Pediatric Recipient of Stem Cell Transplant with CMV Infection.

Suradej Hongeng, MD, Siriorn Watcharananan, MD, Usanarat Anurathapan, MD, Wisutwadee Piyatuctsanawong, Samart Pakakasama, MD, Nongnuch Sirachainan, MD, Sayomporn Sirinavin, MD, Wasan Chantratita, PhD

Blood (2007) 110 (11): 5010.

https://doi.org/10.1182/blood.V110.11.5010.5010

Published: 2007

Journal Articles

Association between Genetic Polymorphisms of β-Cell Differentiation Genes and Insulin Resistance (β-Cell Dysfunction) in Childhood Acute Lymphoblastic Leukemia (ALL) Survivors.

Pacharapan Surapolchai, MD, Suradej Hongeng, MD, Samart Pakakasama, MD, Pat Mahachoklertwattana, MD, Angkana Winaichatsak, MD, Nittaya Wisanuyothin, MD, Wasun Chantratita, MD, Nongnuch Sirachainan, MD

Blood (2007) 110 (11): 4281.

https://doi.org/10.1182/blood.V110.11.4281.4281

Published: 2007

Journal Articles

Reduced Intensity Hematopoietic Stem Cell Transplantation for Treatment of Class 3 Lucarelli Severe Thalassemia Patients.

Suradej Hongeng, MD, Samart Pakakasama, MD, Ampaiwan Chuansumrit, MD, Nongnuch Sirachainan, MD, Thanyachai Sura, MD, Suporn Chancharunee, MD, Artit Ungkanont, MD, Saengsuree Jootar, MD

Blood (2006) 108 (11): 5364.

https://doi.org/10.1182/blood.V108.11.5364.5364

Published: 2006

Journal Articles

Outcomes of Transplantation with Matched-Related Donor (MRD) and Alternative Donor (AD) Stem Cells in Children with Severe Thalassemia.

Suradej Hongeng, MD, Samart Pakakasama, MD, Ampaiwan Chuansumrit, MD, Nongnuch Sirachainan, MD, Watana Chaisiripoomkere, MD, Artit Ungkanont, MD, Saengsuree Jootar, MD

Blood (2004) 104 (11): 2160.

https://doi.org/10.1182/blood.V104.11.2160.2160

Published: 2004

Journal Articles

Single Nucleotide Polymorphisms of DNA Synthetic and Repair Enzymes and Risk of Childhood Acute Lymphoblastic Leukemia.

Samart Pakakasama, MD, Thanasan Sirirat, MSc, Saowanee Kajanachumpol, MSc, Ampaiwan Chaunsumrit, MD, Suradej Hongeng, MD

Blood (2004) 104 (11): 4447.

https://doi.org/10.1182/blood.V104.11.4447.4447

Published: 2004

NARROW

Haplo-Identical Stem Cell Transpant Is a Feasible and Safe Treatment Option for Patients with Severe Thalassemia

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression (PTIS) and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: Safe Approach and Excellent Disease Control

Efficacy of Deferasirox on Iron Chelation in Thalassemia Patients After Hematopoietic Stem Cell Transplantation

A Cost-Utility and Budget Impact Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Severe Thalassemic Patients In Thailand.

Outcomes of Children with Acute Lymphoblastic Leukemia Treated with 2 Consecutive Protocols: Ramathibodi Hospital Experience

Genetic Polymorphisms of β-Cell Differentiation Confer Risk of Alterations of Glucose Metabolism in Survivors of Childhood Acute Lymphoblastic Leukemia.

The Effectiveness of Recombinant Factor VIIa in the Treatment of Bleeding in Pediatric Patients: A Ten-Year Experience from 1997 to 2007.

Adenovirus and BK Virus Co-Infection in the Pediatric Recipient of Stem Cell Transplant with CMV Infection.

Association between Genetic Polymorphisms of β-Cell Differentiation Genes and Insulin Resistance (β-Cell Dysfunction) in Childhood Acute Lymphoblastic Leukemia (ALL) Survivors.

Reduced Intensity Hematopoietic Stem Cell Transplantation for Treatment of Class 3 Lucarelli Severe Thalassemia Patients.

Outcomes of Transplantation with Matched-Related Donor (MRD) and Alternative Donor (AD) Stem Cells in Children with Severe Thalassemia.

Single Nucleotide Polymorphisms of DNA Synthetic and Repair Enzymes and Risk of Childhood Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only